130 related articles for article (PubMed ID: 9720791)
1. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors.
Gotti C; Balestra B; Moretti M; Rovati GE; Maggi L; Rossoni G; Berti F; Villa L; Pallavicini M; Clementi F
Br J Pharmacol; 1998 Jul; 124(6):1197-206. PubMed ID: 9720791
[TBL] [Abstract][Full Text] [Related]
2. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
3. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
4. Chimeric analysis of a neuronal nicotinic acetylcholine receptor reveals amino acids conferring sensitivity to alpha-bungarotoxin.
Levandoski MM; Lin Y; Moise L; McLaughlin JT; Cooper E; Hawrot E
J Biol Chem; 1999 Sep; 274(37):26113-9. PubMed ID: 10473561
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Pucci S; Bolchi C; Bavo F; Pallavicini M; De Palma C; Renzi M; Fucile S; Benfante R; Di Lascio S; Lattuada D; Bessereau JL; D'Alessandro M; Risson V; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2022 Jan; 175():105959. PubMed ID: 34756924
[TBL] [Abstract][Full Text] [Related]
7. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor subtypes in rat subfornical organ neurons and glial cells.
Ono K; Toyono T; Inenaga K
Neuroscience; 2008 Jun; 154(3):994-1001. PubMed ID: 18495354
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.
Moretti M; Vailati S; Zoli M; Lippi G; Riganti L; Longhi R; Viegi A; Clementi F; Gotti C
Mol Pharmacol; 2004 Jul; 66(1):85-96. PubMed ID: 15213299
[TBL] [Abstract][Full Text] [Related]
10. Recombinant expression of alpha-bungarotoxin in Pichia pastoris facilitates identification of mutant toxins engineered to recognize neuronal nicotinic acetylcholine receptors.
Levandoski MM; Caffery PM; Rogowski RS; Lin Y; Shi QL; Hawrot E
J Neurochem; 2000 Mar; 74(3):1279-89. PubMed ID: 10693962
[TBL] [Abstract][Full Text] [Related]
11. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
[TBL] [Abstract][Full Text] [Related]
12. The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit.
Chen D; Patrick JW
J Biol Chem; 1997 Sep; 272(38):24024-9. PubMed ID: 9295355
[TBL] [Abstract][Full Text] [Related]
13. Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons.
Bibevski S; Zhou Y; McIntosh JM; Zigmond RE; Dunlap ME
J Neurosci; 2000 Jul; 20(13):5076-82. PubMed ID: 10864965
[TBL] [Abstract][Full Text] [Related]
14. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
Marinou M; Tzartos SJ
Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
Marks MJ; Whiteaker P; Collins AC
Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
[TBL] [Abstract][Full Text] [Related]
16. Evidence of a functional alpha7-neuronal nicotinic receptor subtype located on motoneurons of the dorsal motor nucleus of the vagus.
Ferreira M; Ebert SN; Perry DC; Yasuda RP; Baker CM; Dávila-García MI; Kellar KJ; Gillis RA
J Pharmacol Exp Ther; 2001 Feb; 296(2):260-9. PubMed ID: 11160606
[TBL] [Abstract][Full Text] [Related]
17. Functional alpha6-containing nicotinic receptors are present in chick retina.
Vailati S; Hanke W; Bejan A; Barabino B; Longhi R; Balestra B; Moretti M; Clementi F; Gotti C
Mol Pharmacol; 1999 Jul; 56(1):11-9. PubMed ID: 10385679
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain.
Breese CR; Adams C; Logel J; Drebing C; Rollins Y; Barnhart M; Sullivan B; Demasters BK; Freedman R; Leonard S
J Comp Neurol; 1997 Oct; 387(3):385-98. PubMed ID: 9335422
[TBL] [Abstract][Full Text] [Related]
19. The influence of nicotinic receptor subunit composition upon agonist, alpha-bungarotoxin and insecticide (imidacloprid) binding affinity.
Lansdell SJ; Millar NS
Neuropharmacology; 2000 Feb; 39(4):671-9. PubMed ID: 10728888
[TBL] [Abstract][Full Text] [Related]
20. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
